Truist Financial Issues Pessimistic Forecast for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare (NYSE:HCA) had its price objective dropped by Truist Financial from $430.00 to $390.00 in a research note issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Truist Financial’s price objective indicates a potential upside of 31.45% from the company’s previous close.

HCA has been the topic of a number of other research reports. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and dropped their price target for the company from $400.00 to $320.00 in a research note on Monday, November 25th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. Morgan Stanley reduced their target price on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $388.60.

HCA Healthcare Trading Down 0.4 %

Shares of HCA Healthcare stock opened at $296.70 on Monday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare has a fifty-two week low of $271.13 and a fifty-two week high of $417.14. The firm has a 50-day simple moving average of $326.93 and a two-hundred day simple moving average of $354.99. The company has a market cap of $75.15 billion, a P/E ratio of 13.32, a price-to-earnings-growth ratio of 1.21 and a beta of 1.64.

Insider Buying and Selling

In other news, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On HCA Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. Benjamin F. Edwards & Company Inc. purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $33,000. Legacy Investment Solutions LLC purchased a new position in shares of HCA Healthcare during the third quarter worth about $39,000. Canoe Financial LP acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $41,000. Capital Performance Advisors LLP purchased a new stake in HCA Healthcare in the third quarter valued at approximately $41,000. Finally, Northwest Investment Counselors LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at $44,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.